Impacts of Positive Margins and Surgical Extent on Outcomes After Early-Stage Lung Cancer Resection
-
Published:2024-06
Issue:
Volume:
Page:
-
ISSN:0003-4975
-
Container-title:The Annals of Thoracic Surgery
-
language:en
-
Short-container-title:The Annals of Thoracic Surgery
Author:
Wong Lye-YengORCID,
Dale Reid,
Kapula Ntemena,
Elliott Irmina A.,
Liou Douglas Z.,
Backhus Leah M.,
Lui Natalie S.,
Shrager Joseph B.,
Berry Mark F.
Reference19 articles.
1. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503);Altorki;Lancet Respir Med,2018
2. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer;Altorki;N Engl J Med,2023
3. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial;Saji;Lancet,2022
4. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery;Hancock;Ann Thorac Surg,2015
5. Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model;Wright;Ann Thorac Surg,2008